Acelot Inc is a drug development company applying patented searching and mining algorithms to complex biological and chemical data to discover new leads for central nervous system diseases, including Alzheimer's and Parkinson's, and various types of cancer. The firmâs ability to analyze large biological pathways opens up new and previously unknown options for drug targets. Acelot's unique graph-based in-silico algorithm approach results in small molecule leads that are tailored to biological targets and screen against undesired targets, minimizing the risk of side-effects.
